THE ROLE OF GUT MICROBIOTA MODULATION IN THE TREATMENT OF CARDIOVASCULAR DISEASES

Abstract

Cardiovascular diseases (CVDs) are the leading cause of mortality worldwide, causing significant impacts on quality of life and generating high costs for public health systems. Risk factors such as arterial hypertension, diabetes mellitus, and obesity contribute to the progression of these conditions, despite therapeutic advances. The etiology of CVDs involves genetic and metabolic factors, with increasing emphasis on the influence of gut microbiota and diet on the prevention and treatment of these diseases. This study aimed to evaluate, through scientific literature, the effects of gut microbiota on the treatment of cardiovascular diseases. A narrative literature review was conducted using scientific databases such as PubMed. Original studies, systematic reviews, meta-analyses, and guidelines relevant to the topic were included. The results demonstrated that the replacement of fresh foods with processed and ultra-processed foods is associated with changes in gut microbiota composition. Epidemiological evidence indicates that low dietary fiber intake is related to an increased risk of CVDs, diabetes mellitus, and colorectal cancer. Short-chain fatty acids, produced by the fermentation of non-digestible carbohydrates, play an important role in modulating cellular activity and cardiovascular health. Furthermore, the Mediterranean dietary pattern shows strong evidence in the prevention of cardiometabolic diseases. It is concluded that, although gut microbiota modulation in patients with CVDs is not yet fully elucidated, reducing the intake of ultra-processed foods and increasing fiber consumption favor bacterial diversity and cardiovascular health.

Author Biographies

Letícia Aparecida Barufi Fernandes, Centro Universitário de Votuporanga- Unifev

Nutritionist, Master’s and PhD in Health Sciences – School of Medicine of São José do Rio Preto (FAMERP), student in the Clinical Nutrition Specialization Program at the Ribeirão Preto Medical School, University of São Paulo (FMRP/USP).

Phelipe Elias da Silva, Universidade Federal de Uberlândia.

Dentist, Master’s in Applied Cellular and Structural Biology – UFU, PhD candidate in Clinical Dentistry – FOUFU; School of Dentistry, Federal University of Uberlândia.

Heitor Bernardes Pereira Delfino, Universidade Federal de Uberlândia.

Nutritionist, Master’s in Physiology and PhD in Medicine (Internal Medicine) – FMRP/USP. Associate Professor and advisor in the Clinical Nutrition Specialization Program at the Ribeirão Preto Medical School, University of São Paulo (FMRP/USP). Professor in the Department of Collective Health at the Faculty of Medicine, Federal University of Uberlândia.

References

ARNETT, D. K. et al. 2019 ACC/AHA guideline on primary prevention of cardiovascular disease: a report from the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 140(11), e596–e646, 2019. https://doi.org/10.1161/CIR.00000000000006

BRASIL. Ministério da Saúde. Doenças cardiovasculares: principal causa de morte no mundo pode ser prevenida. Brasília, DF: Ministério da Saúde, 2022. Disponível em: https://www.gov.br/saude/pt-br/noticias/saude-e-vigilancia-sanitaria/2022/setembro/doencas-cardiovasculares-principal-causa-de-morte-no-mundo-pode-ser-prevenida Acesso em: 29 out. 2025.

BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde e Ambiente. Departamento de Análise Epidemiológica e Vigilância de Doenças Não Transmissíveis. Vigitel Brasil 2023: vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico. Brasília, DF: Ministério da Saúde, 2023. Acesso em: 5 nov. 2025.

CHOROSZY, M. et al. Human gut microbiota in coronary artery disease: a systematic review and meta-analysis. Metabolites, 12(12), 1165, 2022. https://doi.org/10.3390/metabo12121165

FROST, G. et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nature Communications, 5, 3611, 2014. https://doi.org/10.1038/ncomms4611

GARCIA-MANTRANA, I. et al. Shifts on gut microbiota associated to Mediterranean diet adherence and specific dietary intakes on general adult population. Frontiers in Microbiology, 9, 890, 2018. https://doi.org/10.3389/fmicb.2018.00890

GARCÍA-GAVILÁN, J. F. et al. Effect of 1-year lifestyle intervention with energy-reduced Mediterranean diet and physical activity promotion on the gut metabolome and microbiota: a randomized clinical trial. The American Journal of Clinical Nutrition, 119(5), 1143–1154, 2024. https://doi.org/10.1016/j.ajcnut.2024.02.021

GOUGH, E.; SHAIKH, H.; MANGES, A. R. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for Clostridium difficile infection. Clinical Infectious Diseases, 53(10), 994–1002, 2011. https://doi.org/10.1093/cid/cir632

HEIANZA, Y. et al. Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death. Journal of the American Heart Association, 6(7), e004947, 2017. https://doi.org/10.1161/JAHA.116.004947

INSTITUTE FOR HEALTH METRICS AND EVALUATION (IHME). Global Health Data Exchange. Seattle, WA, 2019. Disponível em: https://ghdx.healthdata.org/ Acesso em: 4 nov. 2025.

JATENE, I. B.; NACIF, S. A. P. Epidemiologia das doenças cardiovasculares na mulher. Revista da Sociedade de Cardiologia do Estado de São Paulo, 33(2), 261–263, 2023. https://doi.org/10.29381/0103-8559/20233302261-3

KIMBLE, R. et al. Effects of a Mediterranean diet on gut microbiota and microbial metabolites. Critical Reviews in Food Science and Nutrition, 63(27), 8698–8719, 2022. https://doi.org/10.1080/10408398.2022.2057416

LANE, M. M. et al. Ultra-processed food exposure and adverse health outcomes. BMJ, 384, e077310, 2024. https://doi.org/10.1136/bmj-2023-077310

MARIAT, D. et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiology, 9, 123, 2009. https://doi.org/10.1186/1471-2180-9-123

MARTINS, D. et al. Unravelling the gut microbiome role in cardiovascular disease. Biomolecules, 14(6), 731, 2024. https://doi.org/10.3390/biom14060731

MESLIER, V. et al. Mediterranean diet intervention alters gut microbiome independently of energy intake. Gut, 69, 1258–1268, 2020. https://doi.org/10.1136/gutjnl-2019-320438

NESCI, A. et al. Gut microbiota and cardiovascular disease. International Journal of Molecular Sciences, 24(10), 9087, 2023. https://doi.org/10.3390/ijms24109087

PRÉCOMA, D. B. et al. Atualização da diretriz de prevenção cardiovascular da Sociedade Brasileira de Cardiologia – 2019. Arquivos Brasileiros de Cardiologia, 113(4), 787–891, 2019.

ROSATO, V. et al. Mediterranean diet and cardiovascular disease. European Journal of Nutrition, 58(1), 173–191, 2019. https://doi.org/10.1007/s00394-017-1582-0

VADUGANATHAN, M. et al. Global burden of cardiovascular disease. Journal of the American College of Cardiology, 80(25), 2361–2371, 2022. https://doi.org/10.1016/j.jacc.2022.11.005

YU, J. et al. Dietary patterns and gut microbiota in cardiovascular disease prevention. Nutrition Journal, 24(1), 17, 2025. https://doi.org/10.1186/s12937-024-01060-x

How to Cite

Aparecida Barufi Fernandes, L., Elias da Silva, P. ., & Bernardes Pereira Delfino, H. . (2026). THE ROLE OF GUT MICROBIOTA MODULATION IN THE TREATMENT OF CARDIOVASCULAR DISEASES. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218, 7(5), e757916. https://doi.org/10.47820/recima21.v7i5.7916